المؤلفون: Towse, Adrian, Fenwick, Elisabeth

المصدر: Value in Health ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2024.03.2196Test
https://api.elsevier.com/content/article/PII:S1098301524023325?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301524023325?httpAccept=text/plainTest

المؤلفون: Palmer, Stephen J., Borget, Isabelle, Friede, Tim, Husereau, Don R., Karnon, Jonathan D., Kearns, Ben C., Medin, Emma, Peterse, Elisabeth F.P., Klijn, Sven L., Verburg-Baltussen, Elisabeth J.M., Fenwick, Elisabeth Ae L., Borrill, John

المساهمون: University of York York, UK, Institut Gustave Roussy (IGR), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique Gustave Roussy, Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), University Medical Center Göttingen (UMG), University of Ottawa Ottawa, Flinders University Adelaide, Australia, University of Sheffield Sheffield, Karolinska Institutet Stockholm, Open Health (Pharmerit International), Bristol-Myers Squibb, BMS, National Institute for Health and Care Research, NIHR, Conflict of Interest Disclosures: Messrs Palmer, and Borrill, Drs Borget, Friede, Karnon, Kearns, Medin, Peterse, Verburg-Baltussen, and Fenwick reported receiving personal fees from Bristol Myers Squibb during the conduct of the study. Dr Friede reported receiving personal fees from Bayer, CSL Behring, Galapagos, Minoryx, Novartis, Roche, Vifor, LivaNova, Fresenius Kabi, BiosenseWebster, Janssen, Enanta, Eli Lilly, and IQVIA outside the submitted work. Mr Husereau reported receiving personal fees from GSK and Roche outside the submitted work. Dr Kearns reported receiving grants from National Institute for Health and Care Research outside the submitted work. Mr Klijn reported receiving grants and other fees from Bristol Myers Squibb during the conduct of the study. Dr Fenwick reported receiving grants from Bristol Myers Squibb during the conduct of the study. No other disclosures were reported., Funding/Support: This research was supported by Bristol Myers Squibb .

المصدر: ISSN: 1098-3015.

مصطلحات موضوعية: algorithm, cancer, extrapolation, immunotherapy, survival analysis, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35970706; hal-04122319; https://hal.science/hal-04122319Test; https://hal.science/hal-04122319/documentTest; https://hal.science/hal-04122319/file/1-s2.0-S1098301522021052-main.pdfTest; PUBMED: 35970706

الإتاحة: https://doi.org/10.1016/j.jval.2022.07.009Test
https://hal.science/hal-04122319Test
https://hal.science/hal-04122319/documentTest
https://hal.science/hal-04122319/file/1-s2.0-S1098301522021052-main.pdfTest

المؤلفون: Fenwick, Elisabeth, Eze, Adaeze, D'Hooghe, Thomas, Pandey, Shruti, Chaudhari, Vivek S., Ostawal, Amrita, Luyten, Jeroen, Harty, Gerard

المصدر: Best Practice & Research Clinical Obstetrics & Gynaecology ; volume 89, page 102340 ; ISSN 1521-6934

مصطلحات موضوعية: Obstetrics and Gynecology, General Medicine

الإتاحة: https://doi.org/10.1016/j.bpobgyn.2023.102340Test
https://api.elsevier.com/content/article/PII:S1521693423000408?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1521693423000408?httpAccept=text/plainTest

المؤلفون: Postma, Maarten J., Noone, Declan, Rozenbaum, Mark H., Carter, John A., Botteman, Marc F., Fenwick, Elisabeth, Garrison, Louis P.

المصدر: Postma , M J , Noone , D , Rozenbaum , M H , Carter , J A , Botteman , M F , Fenwick , E & Garrison , L P 2022 , ' Assessing the value of orphan drugs using conventional cost-effectiveness analysis : Is it fit for purpose? ' , Orphanet journal of rare diseases , vol. 17 , no. 1 , 157 . https://doi.org/10.1186/s13023-022-02283-zTest

مصطلحات موضوعية: Health equity, Orphan drug policy, Pharmaceutical policy, Rare diseases, Value of life, Value-based pricing

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/dbc4a82a-1d26-44b1-ab98-1021ecdca3feTest

الإتاحة: https://doi.org/10.1186/s13023-022-02283-zTest
https://hdl.handle.net/11370/dbc4a82a-1d26-44b1-ab98-1021ecdca3feTest
https://research.rug.nl/en/publications/dbc4a82a-1d26-44b1-ab98-1021ecdca3feTest
https://pure.rug.nl/ws/files/216918105/Assessing_the_value_of_orphan_drugs_using_conventional_cost_effectiveness_analysis_Is_it_fit_for_purpose_.pdfTest
http://www.scopus.com/inward/record.url?scp=85127594287&partnerID=8YFLogxKTest

المؤلفون: Piena, Marjanne A., Kroep, Sonja, Simons, Claire, Fenwick, Elisabeth, Harty, Gerard T., Wong, Schiffon L., van Hout, Ben A.

المصدر: Advances in Therapy ; volume 39, issue 2, page 909-909 ; ISSN 0741-238X 1865-8652

مصطلحات موضوعية: Pharmacology (medical), General Medicine

الإتاحة: https://doi.org/10.1007/s12325-021-02032-xTest

المؤلفون: Fenwick, Elisabeth

مصطلحات موضوعية: 338.43362101519542

الإتاحة: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.423768Test

المؤلفون: Geue, Claudia, Wu, Olivia, Xin, Yiqiao, Heggie, Robert, Hutchinson, Sharon, Martin, Natasha K, Fenwick, Elisabeth, Goldberg, David

المصدر: PLOS ONE. 10(12)

مصطلحات موضوعية: Economics, Biomedical and Clinical Sciences, Applied Economics, Hepatitis - C, Prevention, Emerging Infectious Diseases, Clinical Research, Health Services, Digestive Diseases, Liver Disease, Cost Effectiveness Research, Infectious Diseases, Chronic Liver Disease and Cirrhosis, Comparative Effectiveness Research, HIV/AIDS, Hepatitis, Hepatitis - B, 4.2 Evaluation of markers and technologies, 8.2 Health and welfare economics, Aetiology, Detection, screening and diagnosis, 2.5 Research design and methodologies (aetiology), Health and social care services research, Infection, Good Health and Well Being, Costs and Cost Analysis, Hepacivirus, Hepatitis B, Hepatitis B virus, Hepatitis C, Humans, Mass Screening, Models, Economic, Consortium, ECDC, General Science & Technology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/882765r5Test

المؤلفون: Piena, Marjanne A., Kroep, Sonja, Simons, Claire, Fenwick, Elisabeth, Harty, Gerard T., Wong, Schiffon L., van Hout, Ben A.

المساهمون: EMD Serono, an affiliate of Merck KGaA

المصدر: Advances in Therapy ; volume 39, issue 2, page 892-908 ; ISSN 0741-238X 1865-8652

مصطلحات موضوعية: Pharmacology (medical), General Medicine

الإتاحة: https://doi.org/10.1007/s12325-021-01975-5Test

المؤلفون: Rothery, Claire, Strong, Mark, Koffijberg, Hendrik (Erik), Basu, Anirban, Ghabri, Salah, Knies, Saskia, Murray, James F., Sanders Schmidler, Gillian D., Steuten, Lotte, Fenwick, Elisabeth

المصدر: Value in Health ; volume 23, issue 3, page 277-286 ; ISSN 1098-3015

الإتاحة: https://doi.org/10.1016/j.jval.2020.01.004Test
https://api.elsevier.com/content/article/PII:S109830152030036X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S109830152030036X?httpAccept=text/plainTest

المؤلفون: Fenwick, Elisabeth, Steuten, Lotte, Knies, Saskia, Ghabri, Salah, Basu, Anirban, Murray, James F., Koffijberg, Hendrik (Erik), Strong, Mark, Sanders Schmidler, Gillian D., Rothery, Claire

المصدر: Value in Health ; volume 23, issue 2, page 139-150 ; ISSN 1098-3015

الإتاحة: https://doi.org/10.1016/j.jval.2020.01.001Test
https://api.elsevier.com/content/article/PII:S1098301520300279?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301520300279?httpAccept=text/plainTest